Intrinsic Value

LDX doesn't have a meaningful market cap.

The intrinsic value of Lumos Diagnostics Holdings Ltd (LDX) under the Base Case is 0.05 AUD per share. Compared with the current market price of 0.09 AUD, the stock appears Overvalued by 43% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

LDX Intrinsic Value
AU$0.05
Overvaluation 43%
Intrinsic Value
Price AU$0.09
L

LDX is valued in line with its history. A premium of this size has been typical over the past 5 years.

Monitor LDX
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value AU$0.04
Get notified when the price drops into your buy zone
Current Price AU$0.09
Intrinsic Value AU$0.05
Margin of Safety 20% AU$0.04
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to LDX

Fundamental Analysis

What Lumos Diagnostics Does

Health Care

Lumos Diagnostics makes rapid diagnostic tests and the small reader devices that can help clinics and doctors get results at the point of care instead of sending samples to a central lab. Its products are designed for use in settings such as doctor’s offices, urgent care centers, hospitals, and drug trial sites where fast decisions matter.

Headquarters
Australia AU
IPO date
Jul 5, 2021
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Lumos Diagnostics Holdings Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one LDX stock?

The intrinsic value for Lumos Diagnostics Holdings Ltd (LDX) under the Base Case is 0.05 AUD.

Is LDX stock undervalued or overvalued?

Compared with the current market price of 0.09 AUD, the stock appears Overvalued by 43% .

Back to Top